Registration is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event MPOX 2025: Navigating the Global Public Health Emergency Featuring GeoVax CEO On March 6, 2025ATLANTA, GA - March 4, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announces that Chairman & CEO, David Dodd will present at Tribe Public’s CEO Presentation and Q&A Webinar Event titled “MPOX 2025: Navigating the Global Public Health Emergency.” The Event is scheduled to begin at 8:30am Pacific/11:30am Eastern on Thursday, March 6, 2025.
GeoVax Highlights the Critical Role of MVA-Based Vaccines in U.S. Biodefense StrategySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public HealthGeoVax’s Vaccine Development Programs Align with Anticipated HHS Focus on Vaccine Safety, Diversification and Domestic Biosecurity
Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine CapabilityAddressing Critical U.S. Vulnerabilities in Vaccine Supply and National Preparedness
GeoVax Response to WHO's Third Declaration of Mpox as a Public Health Emergency of International ConcernSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health PreparednessSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Highlights the Role of MVA-Based Vaccines in Advancing Public Health PreparednessRecent Studies Support Diversified Vaccine Strategies, Aligning with GeoVax’s MVA-Based GEO-CM04S1 for Enhanced Protection, Particularly for Immunocompromised Populations
Mpox Clade 1 in the U.S. Highlights the Need for Vaccine Supply DiversificationSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Pledges Continued Support for Vaccine Innovation, Transparency, and Public HealthSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Present at the Emerging Growth Conference on February 19, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Congratulates Dr. Valerie Montgomery Rice on Receiving the 2025 Healthcare Champions Lifetime Achievement AwardSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key ProgramsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key ProgramsStrategic Progress Across COVID-19, Mpox, Oncology Therapies and AI Integration Positions GeoVax for Strong Momentum
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor ConferenceSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Showcase Advancements in Vaccines & Immunotherapies at the 2025 BIO CEO & Investor ConferenceATLANTA, GA - February 4, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present GeoVax’s 2025 strategic vision and milestones at the 2025 BIO CEO & Investor Conference, taking place in-person in New York, NY on February 10-12, 2025.
GeoVax Announces Strategic Integration of AI in Support of President Trump's Stargate InitiativeSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Strengthening America's Biosecurity: GeoVax Advances Domestic Vaccine CapabilitySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
